Daunorubicin induced Stevens‐Johnson syndrome: A case report

Abstract

Abstract Clinicians should consider the possible association of Daunorubicin with Stevens‐Johnson syndrome (SJS), administer it with caution and promptly evaluate all subsequently developing cutaneous reactions with a high index of suspicion for Stevens‐Johnson syndrome.

Keywords

• chemotherapy
• daunorubicin
• hypersensitivity reaction
• Stevens‐Johnson syndrome/toxic epidermal necrolysis